Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study. [electronic resource]
- CNS drugs 01 2020
- 103-116 p. digital
Administration, Cutaneous Adult Aged, 80 and over Asian People Female Humans Male Middle Aged Piperazines--adverse effects Piperidines--adverse effects Schizophrenia--drug therapy Transdermal Patch--adverse effects Treatment Outcome